Wolfgang Oster

5.3k total citations · 1 hit paper
101 papers, 3.0k citations indexed

About

Wolfgang Oster is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Wolfgang Oster has authored 101 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 36 papers in Molecular Biology and 30 papers in Hematology. Recurrent topics in Wolfgang Oster's work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (14 papers) and Glioma Diagnosis and Treatment (13 papers). Wolfgang Oster is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (14 papers) and Glioma Diagnosis and Treatment (13 papers). Wolfgang Oster collaborates with scholars based in Germany, United States and United Kingdom. Wolfgang Oster's co-authors include F. Herrmann, A. Lindemann, R Mertelsmann, Roland Mertelsmann, Lesley Russell, Volker Rudat, Michael Henke, Rolf Sauer, François Eschwège and Alain Monnier and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Wolfgang Oster

97 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer

2000 623 citations Wolfgang Oster et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Wolfgang Oster

Since Specialization

Citations

This map shows the geographic impact of Wolfgang Oster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Oster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Oster more than expected).

Fields of papers citing papers by Wolfgang Oster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Oster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Oster. The network helps show where Wolfgang Oster may publish in the future.

Co-authorship network of co-authors of Wolfgang Oster

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Oster. A scholar is included among the top collaborators of Wolfgang Oster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Oster. Wolfgang Oster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia 2019 ·Leukemia ·Takenobu Nii, Varun V. Prabhu, Vivian Ruvolo, Neel S. Madhukar, Ran Zhao, Hong Mu, Lauren Heese, Yuki Nishida, Kensuke Kojima, Mathew J. Garnett, Ultan McDermott, Cyril H. Benes, (unknown), Sean Deacon, Olivier Elemento, Joshua E. Allen, Wolfgang Oster, Martin Stogniew, Jo Ishizawa, Michael Andreeff	50
2	ONC201 IN COMBINATION WITH RADIATION EXHIBITS SYNERGISTIC EFFICACY IN HIGH GRADE GLIOMAS AND OTHER ADVANCED CANCERS 2018 ·Neuro-Oncology ·Rohinton S. Tarapore, Sachin R. Jhawar, Mark N. Stein, (unknown), Andrew Zloza, (unknown), (unknown), Francesca Amoroso, Ian G. Mills, Wolfgang Oster, Joseph D. Allen	1
3	ONC201 Demonstrates Antitumor Effects in Both Triple-Negative and Non–Triple-Negative Breast Cancers through TRAIL-Dependent and TRAIL-Independent Mechanisms 2017 ·Molecular Cancer Therapeutics ·Marie D. Ralff, C. Leah B. Kline, (unknown), Jessica Wagner, Bora Lim, David T. Dicker, Varun V. Prabhu, Wolfgang Oster, Wafik S. El‐Deiry	38
4	Treatment of Patients with Anemia of Malignancy with Recombinant Human Erythropoietin 2015 ·Contributions to nephrology ·Eva Herrmann, Wolfgang Oster, R Mertelsmann	0
5	The Role of Erythropoietin in Patients with Anemia and Normal Renal Function 2015 ·Contributions to nephrology ·Wolfgang Oster, Roland Mertelsmann	0
6	Gemcitabine for relapsed or resistant lymphoma 2000 ·Annals of Oncology ·David G. Savage, (unknown), (unknown), T. J. Garrett, Wolfgang Oster, (unknown), José M. Ruiz, Daniel F. Heitjan, Mary Louise Keohan, Maria Flamm, S.A. Johnson	59
7	Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer 1999 ·Annals of Oncology ·A.S.T. Planting, G. Catimel, P.H.M. de Mulder, Alexander de Graeff, (unknown), (unknown), Wolfgang Oster, Jan B. Vermorken	82
8	Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125. 1997 ·Journal of Clinical Oncology ·Gordon Rustin, Ann E. Nelstrop, Michael Crawford, JA Ledermann, H Lambert, (unknown), Joseph J. Johnson, (unknown), Sherry‐Ann Brown, Wolfgang Oster	58
9	577 Amifostine reduces cumulative cisplatin nephrotoxicity 1995 ·European Journal of Cancer ·Robert L. Capizzi, Björn Scheffler, Wolfgang Oster, Nassir Habboubi, P S Schein	3
10	Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences 1995 ·European Journal of Cancer ·Robert L. Capizzi, Wolfgang Oster	38
11	Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study 1995 ·British Journal of Cancer ·DC Betticher, Heather Anderson, (unknown), (unknown), Wolfgang Oster, Nicholas Thatcher	50
12	A phase I–II study of N-(phosphonacetyl)-l-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancer 1994 ·European Journal of Cancer ·Duncan I. Jodrell, Wolfgang Oster, David J. Kerr, Peter Canney, H. Yosef, W P Steward, Stan B. Kaye, Jim Cassidy	2
13	Effect of rhGM-CSF on haematopoietic reconstitution after chemotherapy in small-cell lung cancer 1991 ·Journal of Cancer Research and Clinical Oncology ·K. Havemann, Martine Klausmann, M. Wolf, Jürgen R. Fischer, P. Drings, Wolfgang Oster	6
14	Erythropoietin prevents chemotherapy-induced anemia: Case report 1990 ·Annals of Hematology ·Wolfgang Oster, F. Herrmann, (unknown), H. Gamm, G. Zeile, Thomas Brune, (unknown), Gregor Schulz, Roland Mertelsmann	15
15	Control of blast cell proliferation and differentiation in acute myelogenous leukemia by soluble polypeptide growth factors 1990 ·Klinische Pädiatrie ·François R. Herrmann, Wolfgang Oster, R Mertelsmann	2
16	Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. 1990 ·Journal of Clinical Oncology ·Wolfgang Oster, F. Herrmann, H. Gamm, G. Zeile, A Lindemann, Gerd Müller, Thomas Brune, H. P. Kraemer, Roland Mertelsmann	121
17	Monocyte Interleukin-1 Secretion Is Regulated by the Sequential Action of γ-Interferon and Interleukin-2 Involving Monocyte Surface Expression of Interleukin-2 Receptors 1989 ·Hämatologie und Bluttransfusion ·F. Herrmann, A. Lindemann, S A Cannistra, MA Brach, Wolfgang Oster, James D. Griffin, R Mertelsmann	1
18	Granulocyte/macrophage colony-stimulating factor induces interleukin 1 production by human polymorphonuclear neutrophils. 1988 ·The Journal of Immunology ·A. Lindemann, D Riedel, Wolfgang Oster, S. Meuer, Dietmar Blohm, R Mertelsmann, F. Herrmann	134
19	Incidence of lineage promiscuity in acute myeloblastic leukemia: Diagnostic implications of immunoglobulin and T-cell receptor gene rearrangement analysis and immunological phenotyping 1988 ·Leukemia Research ·Wolfgang Oster, K. König, Wolfgang Ludwig, Arnold Ganser, A. Lindemann, R Mertelsmann, (unknown)	36
20	Leukemic Colony-Forming Cells in Acute Myeloblastic Leukemia: Maturation Hierarchy and Growth Conditions 1987 ·Hämatologie und Bluttransfusion ·F. Herrmann, Wolfgang Oster, A. Lindemann, Arnold Ganser, Bernd Dörken, Walter Knapp, James D. Griffin, R Mertelsmann	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact